Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

The data management of a phase III efficacy trial of an 11-valent pneumococcal conjugate vaccine and related satellite studies conducted in the Philippines.

Sanvictores DH, Lucero MG, Nohynek H, Tallo VL, Tanskanen A, Nillos LT, Williams G; ARIVAC Consortium.

BMC Res Notes. 2012 Jun 7;5:274. doi: 10.1186/1756-0500-5-274.

2.

Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a randomized, double-blind, placebo-controlled trial.

Lucero MG, Nohynek H, Williams G, Tallo V, Simões EA, Lupisan S, Sanvictores D, Forsyth S, Puumalainen T, Ugpo J, Lechago M, de Campo M, Abucejo-Ladesma E, Sombrero L, Nissinen A, Soininen A, Ruutu P, Riley I, Mäkelä HP.

Pediatr Infect Dis J. 2009 Jun;28(6):455-62. doi: 10.1097/INF.0b013e31819637af.

PMID:
19483514
3.

Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.

Pavia M, Bianco A, Nobile CG, Marinelli P, Angelillo IF.

Pediatrics. 2009 Jun;123(6):e1103-10. doi: 10.1542/peds.2008-3422.

PMID:
19482744
4.

Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.

Tyo KR, Rosen MM, Zeng W, Yap M, Pwee KH, Ang LW, Shepard DS.

Vaccine. 2011 Sep 2;29(38):6686-94. doi: 10.1016/j.vaccine.2011.06.091. Epub 2011 Jul 13.

PMID:
21745516
5.

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial.

Cutts FT, Zaman SM, Enwere G, Jaffar S, Levine OS, Okoko JB, Oluwalana C, Vaughan A, Obaro SK, Leach A, McAdam KP, Biney E, Saaka M, Onwuchekwa U, Yallop F, Pierce NF, Greenwood BM, Adegbola RA; Gambian Pneumococcal Vaccine Trial Group.

Lancet. 2005 Mar 26-Apr 1;365(9465):1139-46. Erratum in: Lancet. 2005 Jul 2-8;366(9479):28.

PMID:
15794968
6.

Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children.

Kilpi T, Ahman H, Jokinen J, Lankinen KS, Palmu A, Savolainen H, Grönholm M, Leinonen M, Hovi T, Eskola J, Käyhty H, Bohidar N, Sadoff JC, Mäkelä PH; Finnish Otitis Media Study Group.

Clin Infect Dis. 2003 Nov 1;37(9):1155-64. Epub 2003 Oct 7.

7.

IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants.

Soininen A, Nohynek H, Lucero M, Jousimies K, Ugpo J, Williams G, Käyhty H; ARIVAC Consortium.

Vaccine. 2009 May 5;27(20):2680-8. doi: 10.1016/j.vaccine.2009.02.059. Epub 2009 Feb 24.

PMID:
19428879
8.

Pneumococcal conjugate vaccine for young children.

Selman S, Hayes D, Perin LA, Hayes WS.

Manag Care. 2000 Sep;9(9):49-52, 54, 56-7 passim. Review.

9.

Economic evaluation of second generation pneumococcal conjugate vaccines in Norway.

Robberstad B, Frostad CR, Akselsen PE, Kværner KJ, Berstad AK.

Vaccine. 2011 Nov 3;29(47):8564-74. doi: 10.1016/j.vaccine.2011.09.025. Epub 2011 Sep 21.

PMID:
21945264
10.

Cost effectiveness of pneumococcal conjugate vaccination against acute otitis media in children: a review.

Boonacker CW, Broos PH, Sanders EA, Schilder AG, Rovers MM.

Pharmacoeconomics. 2011 Mar;29(3):199-211. doi: 10.2165/11584930-000000000-00000. Review.

PMID:
21250759
11.

Economic and clinical evaluation of a catch-up dose of 13-valent pneumococcal conjugate vaccine in children already immunized with three doses of the 7-valent vaccine in Italy.

Boccalini S, Azzari C, Resti M, Valleriani C, Cortimiglia M, Tiscione E, Bechini A, Bonanni P.

Vaccine. 2011 Nov 28;29(51):9521-8. doi: 10.1016/j.vaccine.2011.10.013. Epub 2011 Oct 18.

PMID:
22008820
12.

Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?

van Kempen MJ, Vermeiren JS, Vaneechoutte M, Claeys G, Veenhoven RH, Rijkers GT, Sanders EA, Dhooge IJ.

Int J Pediatr Otorhinolaryngol. 2006 Feb;70(2):275-85. Epub 2005 Sep 2.

PMID:
16140397
13.

The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine.

Isaacman DJ, Strutton DR, Kalpas EA, Horowicz-Mehler N, Stern LS, Casciano R, Ciuryla V.

Clin Ther. 2008 Feb;30(2):341-57. doi: 10.1016/j.clinthera.2008.02.003. Review.

PMID:
18343273
14.

Safety and efficacy of the seven-valent pneumococcal conjugate vaccine: evidence from Northern California.

Black S, Shinefield H.

Eur J Pediatr. 2002 Dec;161 Suppl 2:S127-31. Epub 2002 Nov 9.

PMID:
12494258
15.

Does a 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine prevent respiratory exacerbations in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: protocol for a randomised controlled trial.

O'Grady KA, Grimwood K, Cripps A, Mulholland EK, Morris P, Torzillo PJ, Wood N, Smith-Vaughan H, Revell A, Wilson A, Van Asperen P, Richmond P, Thornton R, Rablin S, Chang AB.

Trials. 2013 Sep 5;14:282. doi: 10.1186/1745-6215-14-282.

16.

Efficacy of a pneumococcal conjugate vaccine against acute otitis media.

Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, Takala A, Käyhty H, Karma P, Kohberger R, Siber G, Mäkelä PH; Finnish Otitis Media Study Group.

N Engl J Med. 2001 Feb 8;344(6):403-9.

17.

Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age.

Lucero MG, Dulalia VE, Nillos LT, Williams G, Parreño RA, Nohynek H, Riley ID, Makela H.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD004977. doi: 10.1002/14651858.CD004977.pub2. Review.

PMID:
19821336
18.

Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.

Wisløff T, Abrahamsen TG, Bergsaker MA, Løvoll Ø, Møller P, Pedersen MK, Kristiansen IS.

Vaccine. 2006 Jul 17;24(29-30):5690-9. Epub 2006 May 5.

PMID:
16735083
19.

The cost-effectiveness of pneumococcal conjugate vaccination in Australia.

Butler JR, McIntyre P, MacIntyre CR, Gilmour R, Howarth AL, Sander B.

Vaccine. 2004 Mar 12;22(9-10):1138-49.

PMID:
15003641
20.

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection.

Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N; Vaccine Trialists Group.

N Engl J Med. 2003 Oct 2;349(14):1341-8.

Items per page

Supplemental Content

Write to the Help Desk